How many benefit plans does Asklepios Biopharmaceutical, Inc. report on Form 5500?

Asklepios Biopharmaceutical, Inc. (EIN 20-0267834) reports 1 benefit plan(s) in the loaded Form 5500 dataset.

What is the EIN for Asklepios Biopharmaceutical, Inc.?

The Employer Identification Number (EIN) reported for Asklepios Biopharmaceutical, Inc. is 20-0267834.

What is the latest Form 5500 filing year for Asklepios Biopharmaceutical, Inc.?

The latest loaded Form 5500 filing year for Asklepios Biopharmaceutical, Inc. is 2023.

Asklepios Biopharmaceutical, Inc. — Form 5500 filings & benefit plans

Form 5500 plan sponsor summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Asklepios Biopharmaceutical, Inc. (EIN 20-0267834) is a plan sponsor located in Durham, NC with 1 reported benefit plan(s) in the loaded dataset. The latest loaded Form 5500 filing year is 2023.

Company overview (based on loaded 2023 public filings)

EIN: 20-0267834
Location: Durham, NC
Loaded plans: 2
Latest filing year: 2023

Reported financial aggregate (2023)

Reported net position

Total reported assets (EOY): $22,014,629
Total reported liabilities (EOY): $0
Total reported net assets (EOY): $22,014,629

Contributions & income

Employer contributions: $2,105,065
Participant contributions: $4,585,502
Total income / additions: $11,100,257

Expenses & distributions

Benefits paid / distributions: $420,914
Total expenses: $433,255
Net increase / (decrease): $10,667,002

Coverage

Total reported participants: 644
Plans with financial statements: 1
Plans with provider compensation: 1

Totals sum the latest loaded 2023 public Form 5500 filing per plan for this company's plans — one filing per plan, so multiple years are never double-counted. Figures are reported values from loaded Schedule H / I (and Schedule C for provider compensation); fields a plan did not report are treated as missing, not zero. These are not audited or official totals.

Largest loaded plans by reported assets

Asklepios Biopharmaceutical, Inc. plans by reported end-of-year assets
Plan	Plan #	Participants	Reported assets (EOY)	Year
Asklepios Biopharmaceuticals, Inc. 401(K) Plan	001	342	$22,014,629	2023
Asklepios Biopharmaceutical, Inc. Health And Welfare Benefits Plan	501	302	not reported in the loaded dataset	2023

Search all 2 loaded plans for this company →

Latest loaded filings

Most recent loaded Form 5500 filings for Asklepios Biopharmaceutical, Inc.
Year	Plan	Participants	Schedules	Filing
2023	Asklepios Biopharmaceutical, Inc. Health And Welfare Benefits Plan	302	—	20240920164330NAL0007774769001
2023	Asklepios Biopharmaceuticals, Inc. 401(K) Plan	342	H, C	20241009145658NAL0010748659001